COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. a key to enhance disease diagnosis: The PUMA Study

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Herrera, Alejandro Casas ^a   De Oca, Maria Montes ^b   Varela, Maria Victorina López ^c   Aguirre, Carlos ^d   Schiavi, Eduardo ^e   Jardim, Josã R ^f  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d FUNDACIÓN NEUMOLÓGICA COLOMBIANA   (Colombia)

^e Hospital de Rehabilitación Respiratoria María Ferrer   (Argentina)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARGENTINA; ARTICLE; BLACK PERSON; BODY MASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLOMBIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPNEA; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; LOWER LIMIT OF NORMAL; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIMARY MEDICAL CARE; RESPIRATORY TRACT PARAMETERS; SELF REPORT; SOUTH AND CENTRAL AMERICA; SPIROMETRY; URUGUAY; VENEZUELA; WHEEZING; AGED; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; AGED; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 84963811666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152266     Document Type: Article

References (17)

1. Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of Underdiagnosis of COPD in national and international surveys. Chest 2015; 148:971-85. doi: 10.1378/chest.14-2535 PMID: 25950276
2. Menezes AM, Perez-Padilla R, Jardim J, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet 2005; 366:1875-81. PMID: 16310554
3. Talamo C, Montes De Oca M, Halbert R, Perez-Padilla R, Jardim JR, Muiño A, et al. Diagnostic labeling of chronic obstructive pulmonary disease in five Latin American Cities. Chest 2007; 131:60-7.
4. Pérez-Padilla R, Hallal PC, Vázquez-García JC, Muiño A, Máquez M, López MV, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; 4:113-120. PMID: 17530504
5. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting Thorax 2008; 63:402-7. doi: 10.1136/thx.2007.085456 PMID: 18234906
6. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010; 182:673-8. doi: 10.1503/cmaj.091784 PMID: 20371646
7. Vandevoorde J, Verbanck S, Gijssels L, Schuermans D, Devroey D, De Backer J, et al. Early detection of COPD: A case finding study in general practice. Respir Med 2007; 101:525-30. PMID: 16908127
8. Schiavi E, Stirbulov R, Hernández Vecino R, Mercurio S, Di Boscio V, PUMA Team. COPD Screening in Primary Care in Four Latin American Countries: Methodology of the PUMA Study. Arch Bronconeumol 2014; 50:469-74. doi: 10.1016/j.arbres.2014.03.006 PMID: 24816036
9. Perez-Padilla R, Valdivia G, Muiño A, López MV, Márquez MN, Montes De Oca M, et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over. Arch Bronconeumol. 2006; 42:317-325. PMID: 16945261
10. Pérez-Padilla R, Torre Bouscoulet L, Vázquez-García JC, Muiño A, Márquez M, López MV, et al. Spirometry reference values after inhalation of 200 microg of salbutamol. Arch Bronconeumol. 2007; 43:530-534. PMID: 17939906
11. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347-65. doi: 10.1164/rccm.201204-0596PP PMID: 22878278
12. Kurmi OP, Li L, Smith M, Augustyn M, Chen J, Collins R, et al. Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: Baseline results from a prospective cohort of the China Kadoorie Biobank (CKB). BMJ Open Respir Res 2014; 1(1):e000025. doi: 10.1136/bmjresp-2014-000025 PMID: 25478177
13. Caramori G, Bettoncelli G, Tosatto R, Arpinelli F, Visonà G, Invernizzi G, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis 2005; 63:6-12. PMID: 16035558
14. De Miguel Díez J, Izquierdo Alonso JL, Molina París J, Rodríguez González-Moro JM, De Lucas Ramos P, Gaspar Alonso-Vega G. Reliability of chronic obstructive pulmonary disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors. Arch Bronconeumol 2003; 39:203-8 [Article in Spanish]. PMID: 12749802
15. Hueto J, Cebollero P, Pascal I, Cascante JA, Eguía VM, Teruel F, et al. Spirometry in primary care in Navarre, Spain. Arch Bronconeumol 2006; 42:326-31 [Article in Spanish]. PMID: 16945262
16. Arne M, Lisspers K, Ställberg B, Boman G, Hedenström H, Janson C, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010; 104:550-6. doi: 10.1016/j.rmed.2009.10.023 PMID: 19931443
17. Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC, Chang Y, et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis 2013; 8:389-95. doi: 10.2147/COPD.S48659 PMID: 24009418